Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P) is a **pseudogene** derived from the 7SL RNA gene, which codes for the RNA component of the signal recognition particle (SRP)[4][7]. The canonical 7SL RNA plays a central role in targeting newly synthesized secretory and membrane proteins to the endoplasmic reticulum by acting as a scaffold in the SRP complex[3][5][6]. However, **7SL RNA pseudogenes**, such as RN7SL125P, are generally non-functional genetic elements—their sequences resemble the 7SL RNA gene but accumulate mutations, truncations, and are not typically transcribed into functional RNA or protein[1][4][7]. They arose through the process of reverse transcription and random insertion into the genome, explaining their abundance and sequence variability in humans[1][6][7]. RN7SL125P is not considered a therapeutic target, does not have a known role in normal physiology or disease, and has no known drug or biomarker associations[4][7]. **Notes:** - RN7SL125P is a pseudogene and not a functional gene or a protein/molecular target. - 7SL RNA has functional importance, but its pseudogenes (including RN7SL125P) do not have established biological functions or disease roles in current scientific literature[1][3][4][6][7]. - There is nothing to indicate it is a drug target or biomarker; if the intended target is the functional 7SL RNA or the SRP complex, a different entry should be used.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P).